Rather, hepatic steatosis occurs through increased NEFA flow from the diet or adipose tissue and heightened uptake by the liver, facilitated by the elevated levels of fatty acid transporters CD36 and FABP4, as shown here. This evidence concerns the gene CD36 and fatty liver disease.